SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $175,000 | +12.9% | 16,243 | 0.0% | 0.00% | – |
| Q1 2019 | $155,000 | -16.7% | 16,243 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $186,000 | -80.5% | 16,243 | -71.1% | 0.00% | -50.0% |
| Q3 2018 | $954,000 | +16.6% | 56,277 | -2.4% | 0.00% | 0.0% |
| Q2 2018 | $818,000 | -18.4% | 57,633 | +9.2% | 0.00% | -33.3% |
| Q1 2018 | $1,003,000 | +27.0% | 52,773 | +9.5% | 0.00% | +50.0% |
| Q4 2017 | $790,000 | -65.3% | 48,200 | -68.2% | 0.00% | -71.4% |
| Q3 2017 | $2,277,000 | -3.5% | 151,800 | -43.4% | 0.01% | 0.0% |
| Q2 2017 | $2,359,000 | +69.2% | 268,100 | 0.0% | 0.01% | +75.0% |
| Q1 2017 | $1,394,000 | +633.7% | 268,100 | +2115.7% | 0.00% | +300.0% |
| Q1 2015 | $190,000 | – | 12,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |